Results 181 to 190 of about 1,915,304 (214)
Some of the next articles are maybe not open access.
Drug‐Eluting Balloon Angioplasty for In‐Stent Restenosis Following Carotid Artery Stent Placement
Journal of Neuroimaging, 2020Drug‐eluting balloons (DEBs) have been proposed as an option for the treatment of in‐stent restenosis (ISR) following carotid artery stent placement. We report our experience and review of literature to provide additional data.
Kunal Bhatia +6 more
semanticscholar +1 more source
Thirty-six-month outcomes of drug-eluting balloon angioplasty in the infrapopliteal arteries
Objectives To evaluate 36-month outcomes of drug-eluting balloons in infrapopliteal (=below-the-knee) arterial segments, we made a prospective registry enrolling patients (Rutherford class 2 to 5, ankle–brachial index 0.4–0.7) who were revascularized ...
B. Ozpak, Ş. Bozok, M. Cayir
semanticscholar +2 more sources
Radiology, 2018
Purpose To compare lesion primary patency and restenosis rates between drug-eluting balloon (DEB) percutaneous transluminal angioplasty (PTA) and conventional balloon PTA (cPTA) in the treatment of arteriovenous fistula (AVF) and arteriovenous graft (AVG)
F. Irani +13 more
semanticscholar +1 more source
Purpose To compare lesion primary patency and restenosis rates between drug-eluting balloon (DEB) percutaneous transluminal angioplasty (PTA) and conventional balloon PTA (cPTA) in the treatment of arteriovenous fistula (AVF) and arteriovenous graft (AVG)
F. Irani +13 more
semanticscholar +1 more source
American Heart Journal
BACKGROUND Repeat drug-eluting stenting is superior to balloon angioplasty for prevention of recurrent in-stent restenosis (ISR), but carries a potential disadvantage of multiple layers of stent.
D. Cutlip +8 more
semanticscholar +1 more source
BACKGROUND Repeat drug-eluting stenting is superior to balloon angioplasty for prevention of recurrent in-stent restenosis (ISR), but carries a potential disadvantage of multiple layers of stent.
D. Cutlip +8 more
semanticscholar +1 more source
Journal of Vascular Access, 2018
Background: Endovascular treatment of autogenous arteriovenous haemodialysis fistula stenosis has high reintervention rates. We investigate the effect of drug-eluting balloons in the treatment of recurrent haemodialysis fistula stenosis. Methods: This is
Jan Swinnen +12 more
semanticscholar +1 more source
Background: Endovascular treatment of autogenous arteriovenous haemodialysis fistula stenosis has high reintervention rates. We investigate the effect of drug-eluting balloons in the treatment of recurrent haemodialysis fistula stenosis. Methods: This is
Jan Swinnen +12 more
semanticscholar +1 more source
The Lancet
BACKGROUND Coronary artery calcification is common among patients undergoing percutaneous coronary intervention (PCI), and severe coronary artery lesion calcification is associated with increased procedural complexity, stent under-expansion, and high ...
Ajay J. Kirtane +21 more
semanticscholar +1 more source
BACKGROUND Coronary artery calcification is common among patients undergoing percutaneous coronary intervention (PCI), and severe coronary artery lesion calcification is associated with increased procedural complexity, stent under-expansion, and high ...
Ajay J. Kirtane +21 more
semanticscholar +1 more source
Circulation. Cardiovascular Interventions, 2018
Background: This study assesses clinical outcomes after drug-eluting balloon treatment for recurrent in-stent restenosis lesions based on the number of metallic layers.
H. Yabushita +19 more
semanticscholar +1 more source
Background: This study assesses clinical outcomes after drug-eluting balloon treatment for recurrent in-stent restenosis lesions based on the number of metallic layers.
H. Yabushita +19 more
semanticscholar +1 more source

